Better Hepatitis C Treatment Outcome for Coffee Drinkers
An American study finds that coffee consumption may increase the Hepatitis C treatment success rate.
Continue reading »An American study finds that coffee consumption may increase the Hepatitis C treatment success rate.
Continue reading »Because they offer hope of an improved success rate, Axium's HEPVisions® Program now includes the two recently approved drugs into Hepatitis C treatment.
Continue reading »Everyone gets an occasional nosebleed, but those with Hepatitis C may not only be more prone to them - they also must be aware of the potential for spreading the infectious Hepatitis C virus.
Continue reading »Making it easier to test future Hepatitis C medications and study this challenging virus, researchers have created a humanized mouse with a fully functioning immune system.
Continue reading »In areas where liver specialists are not available, videoconferencing to train primary care providers makes top Hepatitis C treatment attainable.
Continue reading »Practiced much more in Europe than the United States, many believe that homeopathic medicine is an effective way to manage chronic Hepatitis C.
Continue reading »In addition to receiving fast track status from the FDA, setrobuvir has been granted a U.S. patent. Currently in a Phase IIb study, data on setrobuvir's efficacy against Hepatitis C is expected in the latter part of 2011.
Continue reading »A respiratory virus that infects dogs is found to be a close relative of the Hepatitis C virus.
Continue reading »When added to pegylated interferon and ribavirin therapy, Medivir's Hepatitis C protease inhibitor TMC435 was highly safe and effective, a dramatic improvement over the standard treatment in chronic Hepatitis C genotype 1 treatment-experienced individuals.
Continue reading »Because it will more than double the current cost of treatment, the Fair Pricing Coalition is furious about the price affixed to Incivek™, the newest approved Hepatitis C medication.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window